Non classé

The World’s First Practical Method for Measuring the Brain Function of Intensive Care Patients by Cerenion

INTRODUCING A NEW METHOD TO READ
THE PULSE OF THE BRAIN™

Our CERENION C-TREND™technology (pat. pend.) reveals the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient.

FROM STRONG SCIENCE
TO BETTER HEALTHCARE

CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated measure can be integrated into EEG-measurement devices and patient monitors as a software feature.
CERENION C-TREND™ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a simple index that measures the condition and function of the brain on a scale from 0 to 100.
The technology has the potential of improving both the quality and the cost of intensive care.
Read more…
Share
Tags: 2019BRAIN FUNCTIONCERENIONCARE PATIENTS
4 years ago

Recent Posts

Roger Guillemin: Neuroscientist who Showed How the Brain Controls Hormones via Nature

Roger Guillemin identified the molecules in the brain that control the production of hormones in…

Mitigating Multi-Source Hair Damage via Cosmetics and Toiletries

In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…

“If things go in the Wrong Direction, it Could be a Significant Challenge to the Industry”: Cosmetics Europe director on EU Regulations

We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…